$SBPH F-star Therapeutics, Inc. Insider Trading
Get free email notifications about insider trading in F-star Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in F-star Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in F-star Therapeutics, Inc. for free.
CIK Number: 0001566373
IRS Number: 522386345
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: SBPH
Company Address: 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE CB22 3AT
Phone number: 508-473-5993
Former name: Spring Bank Pharmaceuticals, Inc., date of change: 2013-01-08
Market Capitalization: $58.25M
Prev close: $7.50
Average Daily Volume: 13,148
Days Low: $0.00
Year Low: $6.31
Year High: $13.25
F-star Therapeutics, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 07 2021 | SBPH | F-star Therapeutic ... | Benz Edward JR | Director | Option Exercise | A | 6.88 | 20,000 | 137,600 | 20,000 | |
Jun 07 2021 | SBPH | F-star Therapeutic ... | Arkowitz David | Director | Option Exercise | A | 6.88 | 20,000 | 137,600 | 20,000 | |
Mar 11 2021 | SBPH | F-star Therapeutic ... | Forster Eliot | President and CEO | Option Exercise | A | 7.24 | 127,924 | 926,170 | 388,901 | |
Mar 11 2021 | SBPH | F-star Therapeutic ... | Brewis Neil | Chief Scientific Of ... | Option Exercise | A | 7.24 | 22,561 | 163,342 | 99,180 | |
Mar 11 2021 | SBPH | F-star Therapeutic ... | DEPTULA-HICKS DARLENE M | Treasurer and CFO | Option Exercise | A | 7.24 | 25,894 | 187,473 | 54,320 | |
Mar 11 2021 | SBPH | F-star Therapeutic ... | Kayitalire Louis | Chief Medical Offic ... | Option Exercise | A | 7.24 | 12,880 | 93,251 | 40,169 | |
Feb 02 2021 | SBPH | F-star Therapeutic ... | Forster Eliot | President and CEO | Grant | A | 0.00 | 142,000 | 0 | 160,560 | 18.6 K to 160.6 K (+765.09 %) |
Feb 02 2021 | SBPH | F-star Therapeutic ... | Kayitalire Louis | Chief Medical Offic ... | Grant | A | 0.00 | 29,000 | 0 | 55,437 | 26.4 K to 55.4 K (+109.69 %) |
Feb 02 2021 | SBPH | F-star Therapeutic ... | Bermingham Nessan | Director | Grant | A | 0.00 | 87,000 | 0 | 103,875 | 16.9 K to 103.9 K (+515.56 %) |
Feb 02 2021 | SBPH | F-star Therapeutic ... | Benz Edward JR | Director | Grant | A | 0.00 | 4,385 | 0 | 4,385 | 0 to 4.4 K |
Feb 02 2021 | SBPH | F-star Therapeutic ... | DEPTULA-HICKS DARLENE M | Treasurer and CFO | Grant | A | 0.00 | 30,000 | 0 | 56,437 | 26.4 K to 56.4 K (+113.48 %) |
Oct 01 2020 | SBPH | Spring Bank Pharma ... | Brady Todd C | Director | Grant | A | 0.00 | 9,235 | 0 | 60,016 | 50.8 K to 60 K (+18.19 %) |
Oct 01 2020 | SBPH | Spring Bank Pharma ... | CLACKSON TIMOTHY P | Director | Grant | A | 0.00 | 9,422 | 0 | 50,486 | 41.1 K to 50.5 K (+22.94 %) |
Jul 01 2020 | SBPH | Spring Bank Pharma ... | Brady Todd C | Director | Grant | A | 0.00 | 8,418 | 0 | 50,781 | 42.4 K to 50.8 K (+19.87 %) |
Jul 01 2020 | SBPH | Spring Bank Pharma ... | CLACKSON TIMOTHY P | Director | Grant | A | 0.00 | 8,588 | 0 | 41,064 | 32.5 K to 41.1 K (+26.44 %) |